Liu Gang’s Post

What does the future of Alzheimer’s disease diagnostics look like? Professor Henrik Zetterberg shares his perspectives and research on developing next-generation diagnostics for Alzheimer’s, article: https://lnkd.in/dYtUaCeq In the clip, Professor Zetterberg discusses quantitative dried plasma microsampling technology - with only a few drops of dried blood from a finger prick, it’s possible to measure all key blood biomarkers for Alzheimer’s disease, by using ultra-sensitive multiplex technology NULISA (Alamar Biosciences, Inc.). These dried blood samples provide results that align with traditional venous blood draws. These biomarkers are stable in room temperature for up to six months. This opens the door to democratizing Alzheimer’s diagnostics by enabling remote testing, even in areas far from labs.   Professor Zetterberg and his team has used Capitainer®B50 and been one of the first users, pre-launch, of our new device Capitainer®SEP10.

A method for PFAS testing with Capitainer has been developed. The European Environment Agency state in the report “Risks of PFAS for human health in Europe” from 2024 that “Future human biomonitoring will be essential to track long-term trends of previously- and currently-used chemicals like PFAS”. As a background, the report states that “Teenagers in Europe face health risks from exposure to toxic per- and polyfluoroalkyl substances (PFAS) according to a series of studies conducted between 2014 and 2021. Of the teenagers who participated in the studies, an average of 14.3% had blood levels above the health-based guidance value (HBGV), with two countries exceeding 20%.” In a recent publication from University of Turin, the researchers developed a method to test blood levels of PFAS from microsamples collected with Capitainer. The developed method can detect and quantify 25 different PFAS from only 10µL of dried blood. This development enables efficient and easy testing programs with at-home sampling, that perfectly could meet the needs of biomonitoring stated in the report from the European Environmental Agency. Thank you Martina Galletto and Alberto Salomone, for excellent development work. Their paper is available in the link below. Contact us at Capitainer if you want to learn more about human biomonitoring using our sampling solution. #exposome #PFAS #microsampling Link to the report from the European Environment Agency is available here: https://lnkd.in/dXx4tpRn https://lnkd.in/dxb6ZhWc

Exciting first day at the 4th Nordic Metabolomics Conference 2024 in Turku! Lots of interesting discussions and talks about the use of Capitainer ’s microsampling devices in the field of metabolomics and lipidomics. If you are attending, Welcome to stop by the Capitainer/Labema Group booth and the Univ of Florida/Capitainer (Wenqian Li, Liu Gang, Donald Chace,Tim Garrett) poster! #NMetC2024, #microsampling, #metabolomics

Our latest blog post is a publication highlight describing a research study using Capitainer based self-sampling for multiplex proteomics analysis. Capitainer sampling kits were sent out to 2000 randomized consenting adults who collected samples in their own homes. Multiplexed analysis was performed using a 276 plex PEA assay approach from Olink Proteomics. In addition, a multi-analyte serology approach was applied using MagPlex, from Luminex . The study, conducted at SciLifeLab and lead by Claudia Fredolini and Jochen Schwenk, demonstrates the power of at-home sampling approaches and the compatibility of Capitainer samples with state of the art analytical platforms. We hope our post and the publication can inspire other researchers to new pioneering studies. At Capitainer, our specialists are available to support you in conducting your microsampling based studies. #microsampling #lifesciences #proteomics https://lnkd.in/dkmGJEvd

Exciting news! Capitainer is proud to support Chalmers University of Technology in the groundbreaking SCAPIS2-HOME study on precision nutrition. Using our Capitainer®B50 self-sampling card, this innovative research aims to uncover how personalized dietary advice can prevent heart attacks and strokes.   Professor Rikard Landberg who is leading the study states, "This is groundbreaking because, for the first time, we will have the opportunity to directly link how different individuals react to meals — also focusing on long-term health outcomes. The advantage of this study is the extensive and sophisticated investigations into heart and vascular health and lung function which will be conducted, to which our meal outcomes can be linked."   Our CEO, Christopher Aulin, emphasizes, "This research demonstrates the potential of self-sampling and Capitainer's blood sampling solution. It offers the opportunity to conduct large scientific studies more efficiently and with the participants in focus. We are very pleased with the collaboration with Chalmers and that our products can contribute to new knowledge and hopefully preventive measures for major public health issues."   Read the full press release here: https://lnkd.in/dQJvUfze   #Capitainer #selfsampling #SCAPIS

Lasec® Group is now our strategic partner for South- and sub-Saharan Africa as we have signed a new distribution agreement. With over 75 years in business to serve the laboratory and scientific community across Africa, Lasec® is a perfect partner to bring Capitainer to this market. The distribution deal includes the registration of Capitainer products with local authorities, thereby giving Capitainer access to the expanding African market. This will simplify logistics for local customers and large foundations operating on the African continent, with whom Capitainer already has established relationships. We are excited and truly look forward to working together and make Capitainer #microsampling products available for research and healthcare purposes. https://lnkd.in/dsQkqJiS #ScienceForAfrica #Selfsampling #Diagnostics